{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05441592",
            "orgStudyIdInfo": {
                "id": "HUM00210979"
            },
            "organization": {
                "fullName": "University of Michigan",
                "class": "OTHER"
            },
            "briefTitle": "A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery",
            "officialTitle": "A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-randomized-control-trial-assessing-the-effect-of-topical-tranexamic-acid-on-risk-of-hematoma-in-breast-surgery"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-27",
            "studyFirstSubmitQcDate": "2022-06-27",
            "studyFirstPostDateStruct": {
                "date": "2022-07-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-03",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Edwin G. Wilkins",
                "investigatorTitle": "Professor of Surgery",
                "investigatorAffiliation": "University of Michigan"
            },
            "leadSponsor": {
                "name": "University of Michigan",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This trial is being completed to evaluate the safety and efficacy of topical tranexamic acid use in preventing hematomas in routine breast plastic surgery operations."
        },
        "conditionsModule": {
            "conditions": [
                "Hematoma Postoperative"
            ],
            "keywords": [
                "Breast reduction",
                "Gender-affirming mastectomy",
                "Tranexamic Acid"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 500,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Irrigation that contains tranexamic acid (TXA)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Tranexamic acid injection"
                    ]
                },
                {
                    "label": "No additional irrigation usual care",
                    "type": "OTHER",
                    "interventionNames": [
                        "Other: No additional irrigation"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Tranexamic acid injection",
                    "description": "The breast pockets will additionally be irrigated with 150 cc of 2.67% TXA (75 cc in each breast). The TXA solution will be allowed to be sit in the breast pocket for 15 minutes and then removed after 15 minutes.",
                    "armGroupLabels": [
                        "Irrigation that contains tranexamic acid (TXA)"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "No additional irrigation",
                    "description": "There will be no additional irrigation after the standard surgical procedure.",
                    "armGroupLabels": [
                        "No additional irrigation usual care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Hematomas requiring operative washout or aspiration in participants that receive TXA versus participants that do not receive TXA",
                    "timeFrame": "Up to approximately 4 weeks after surgery"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of participants experiencing a major thromboembolic event related to the study drug",
                    "description": "Major thromboembolic events include, but are not limited to: deep vein thrombosis, pulmonary embolism, stroke",
                    "timeFrame": "Up to approximately 4 weeks after surgery"
                },
                {
                    "measure": "Number of participants experiencing major complications other than hematoma",
                    "description": "Major complications include, but are not limited to: infection, seroma, hypersensitivity reaction to TXA, renal impairment",
                    "timeFrame": "Up to approximately 4 weeks after surgery"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients undergoing bilateral breast reduction or bilateral gender-affirming mastectomy\n* For patients undergoing bilateral breast reduction, any skin incision pattern or pedicle is acceptable.\n* For patients undergoing bilateral gender-affirming mastectomy, any skin incision and mastectomy type is acceptable\n\nExclusion Criteria:\n\n* Active thromboembolic disease or history of intrinsic risk of thrombosis or thromboembolism, including retinal vein or artery occlusion\n* Current use of systemic anticoagulation\n* Hypersensitivity to tranexamic acid\n* Concomitant use of combined hormonal contraceptives\n* Use of factor IX complex concentrates, anti-inhibitor coagulant concentrates or all-trans retinoic acid\n* History of acquired defective color vision\n* History of subarachnoid hemorrhage\n* Pregnancy\n* History of renal impairment or serum Creatinine \\>1.5 milligrams per deciliter (mg/dL)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sherry Tang, MD",
                    "role": "CONTACT",
                    "phone": "734-936-5895",
                    "email": "syqtang@med.umich.edu"
                },
                {
                    "name": "Jenni Hamill, MPH",
                    "role": "CONTACT",
                    "email": "Jenberry@med.umich.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Edwin Wilkins, MD",
                    "affiliation": "University of Michigan",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Michigan",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sherry Tang, MD",
                            "role": "CONTACT",
                            "phone": "734-936-5895",
                            "email": "syqtang@umich.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006406",
                    "term": "Hematoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006470",
                    "term": "Hemorrhage"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9493",
                    "name": "Hematoma",
                    "asFound": "Hematoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9556",
                    "name": "Hemorrhage",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014148",
                    "term": "Tranexamic Acid"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000933",
                    "term": "Antifibrinolytic Agents"
                },
                {
                    "id": "D000050299",
                    "term": "Fibrin Modulating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000006490",
                    "term": "Hemostatics"
                },
                {
                    "id": "D000003029",
                    "term": "Coagulants"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16902",
                    "name": "Tranexamic Acid",
                    "asFound": "Non-Small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M4252",
                    "name": "Antifibrinolytic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9576",
                    "name": "Hemostatics",
                    "relevance": "LOW"
                },
                {
                    "id": "M6259",
                    "name": "Coagulants",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Coag",
                    "name": "Coagulants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                }
            ]
        }
    },
    "hasResults": false
}